Advances in medicinal chemistry, Volume 3:
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
[S.l.]
Elsevier Science
1995
|
Schlagworte: | |
Online-Zugang: | Volltext |
Beschreibung: | Volume 3 of Advances in Medicinal Chemistry is comprised of four chapters on diverse aspects of medicinal chemistry. Chapter 1 presents an account of a research program which was started to discover a novel antipsychotic agent with minimal side effects for the treatment, principally, of schizophrenia. Chapter 2 relates an account on the discovery of novel antithrombotic drugs based on the RGD motif through a rational design approach. Chapter 3 presents the medicinal chemistry and preclinical development surrounding sertraline, a very important serotonin reuptake drug for the treatment of endogenous depression. Finally, Chapter 4 gives a summary of a series of boronic acid-based immunosuppressants that operate via inhibition of dipeptidypeptidase IV. |
Beschreibung: | 1 Online-Ressource (1 online resource) |
ISBN: | 9781559387989 155938798X |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV042308337 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 150129s1995 |||| o||u| ||||||eng d | ||
020 | |a 9781559387989 |9 978-1-55938-798-9 | ||
020 | |a 155938798X |9 1-55938-798-X | ||
035 | |a (OCoLC)166344383 | ||
035 | |a (DE-599)BVBBV042308337 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 | ||
082 | 0 | |a 615/.19 |2 22 | |
245 | 1 | 0 | |a Advances in medicinal chemistry, Volume 3 |
264 | 1 | |a [S.l.] |b Elsevier Science |c 1995 | |
300 | |a 1 Online-Ressource (1 online resource) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Volume 3 of Advances in Medicinal Chemistry is comprised of four chapters on diverse aspects of medicinal chemistry. Chapter 1 presents an account of a research program which was started to discover a novel antipsychotic agent with minimal side effects for the treatment, principally, of schizophrenia. Chapter 2 relates an account on the discovery of novel antithrombotic drugs based on the RGD motif through a rational design approach. Chapter 3 presents the medicinal chemistry and preclinical development surrounding sertraline, a very important serotonin reuptake drug for the treatment of endogenous depression. Finally, Chapter 4 gives a summary of a series of boronic acid-based immunosuppressants that operate via inhibition of dipeptidypeptidase IV. | ||
650 | 7 | |a Pharmaceutical chemistry |2 fast | |
650 | 4 | |a Pharmaceutical chemistry | |
700 | 1 | |a Maryanoff, B. E. |e Sonstige |4 oth | |
700 | 1 | |a Maryanoff, C. A. |e Sonstige |4 oth | |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9781559387989 |x Verlag |3 Volltext |
912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
940 | 1 | |q FAW_PDA_ESD | |
940 | 1 | |q FLA_PDA_ESD | |
999 | |a oai:aleph.bib-bvb.de:BVB01-027745329 |
Datensatz im Suchindex
_version_ | 1804152894642978816 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV042308337 |
collection | ZDB-33-ESD ZDB-33-EBS |
ctrlnum | (OCoLC)166344383 (DE-599)BVBBV042308337 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01896nmm a2200373zc 4500</leader><controlfield tag="001">BV042308337</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s1995 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781559387989</subfield><subfield code="9">978-1-55938-798-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">155938798X</subfield><subfield code="9">1-55938-798-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)166344383</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042308337</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in medicinal chemistry, Volume 3</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[S.l.]</subfield><subfield code="b">Elsevier Science</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (1 online resource)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Volume 3 of Advances in Medicinal Chemistry is comprised of four chapters on diverse aspects of medicinal chemistry. Chapter 1 presents an account of a research program which was started to discover a novel antipsychotic agent with minimal side effects for the treatment, principally, of schizophrenia. Chapter 2 relates an account on the discovery of novel antithrombotic drugs based on the RGD motif through a rational design approach. Chapter 3 presents the medicinal chemistry and preclinical development surrounding sertraline, a very important serotonin reuptake drug for the treatment of endogenous depression. Finally, Chapter 4 gives a summary of a series of boronic acid-based immunosuppressants that operate via inhibition of dipeptidypeptidase IV.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical chemistry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical chemistry</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maryanoff, B. E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maryanoff, C. A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9781559387989</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027745329</subfield></datafield></record></collection> |
id | DE-604.BV042308337 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T01:17:58Z |
institution | BVB |
isbn | 9781559387989 155938798X |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027745329 |
oclc_num | 166344383 |
open_access_boolean | |
owner | DE-1046 |
owner_facet | DE-1046 |
physical | 1 Online-Ressource (1 online resource) |
psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD |
publishDate | 1995 |
publishDateSearch | 1995 |
publishDateSort | 1995 |
publisher | Elsevier Science |
record_format | marc |
spelling | Advances in medicinal chemistry, Volume 3 [S.l.] Elsevier Science 1995 1 Online-Ressource (1 online resource) txt rdacontent c rdamedia cr rdacarrier Volume 3 of Advances in Medicinal Chemistry is comprised of four chapters on diverse aspects of medicinal chemistry. Chapter 1 presents an account of a research program which was started to discover a novel antipsychotic agent with minimal side effects for the treatment, principally, of schizophrenia. Chapter 2 relates an account on the discovery of novel antithrombotic drugs based on the RGD motif through a rational design approach. Chapter 3 presents the medicinal chemistry and preclinical development surrounding sertraline, a very important serotonin reuptake drug for the treatment of endogenous depression. Finally, Chapter 4 gives a summary of a series of boronic acid-based immunosuppressants that operate via inhibition of dipeptidypeptidase IV. Pharmaceutical chemistry fast Pharmaceutical chemistry Maryanoff, B. E. Sonstige oth Maryanoff, C. A. Sonstige oth http://www.sciencedirect.com/science/book/9781559387989 Verlag Volltext |
spellingShingle | Advances in medicinal chemistry, Volume 3 Pharmaceutical chemistry fast Pharmaceutical chemistry |
title | Advances in medicinal chemistry, Volume 3 |
title_auth | Advances in medicinal chemistry, Volume 3 |
title_exact_search | Advances in medicinal chemistry, Volume 3 |
title_full | Advances in medicinal chemistry, Volume 3 |
title_fullStr | Advances in medicinal chemistry, Volume 3 |
title_full_unstemmed | Advances in medicinal chemistry, Volume 3 |
title_short | Advances in medicinal chemistry, Volume 3 |
title_sort | advances in medicinal chemistry volume 3 |
topic | Pharmaceutical chemistry fast Pharmaceutical chemistry |
topic_facet | Pharmaceutical chemistry |
url | http://www.sciencedirect.com/science/book/9781559387989 |
work_keys_str_mv | AT maryanoffbe advancesinmedicinalchemistryvolume3 AT maryanoffca advancesinmedicinalchemistryvolume3 |